Issue 2 2022

European Pharmaceutical Review Issue 2 2022

Features in this issue discuss how bioprocessing must adapt to meet the needs of autologous cell therapies, the role of mass spectrometry in enhancing antibody consistency and the economic benefits of embracing continuous manufacturing. Also in this journal, articles exploring the development of precision medicine for chronic diseases, why acoustic emission testing could be of benefit in assessing compressed air pressure vessels and so much more!

Other exclusive content in the issue:

    Setting a new standard of care for liver MRI contrast agents in patients with reduced kidney function
    Carl Bjartmar, Ascelia Pharma
    Engaging the innate immune system to fight cancer effectively
    Arndt Schottelius, Affimed
    Analysis of illicit drugs and wastewater-based epidemiology: current methodological techniques
    Ayman AlSaadi and Wayne G Carter, University of Nottingham
    The future of CMC for novel therapies
    Elena Meurer, Biopharma Excellence